Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Manufacture Drug Delivery, Vaccines

Nanotechnology Versus Cancer

We need a new type of weapon in the war on cancer. Chemotherapy, the backbone of cancer treatment, often brings initial success but cancers are notorious for relapsing in ever more aggressive and resistant forms. Traditional chemotherapies do not discriminate. They attack all rapidly dividing cells and are plagued by a narrow therapeutic index, numerous side effects, and high likelihood of resistance (1). Newer, molecularly targeted agents sidestep many of these problems, but often require lifelong treatment. And because these agents are relatively new, their long-term efficacy and safety are yet to be determined, and it is likely that we will see resistance develop over time.

Read the full article now

Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Ronak Savla

“How many people can truly say that they are working on what they dreamed of as kids? I guess I’m one of the lucky ones.” After learning about the field of nanotechnology as a high school student, Ronak saw the opportunity of combining his interest in science with his passion to help others. Ronak started working in a nanotechnology drug delivery lab during the summer after his freshman year at Rutgers University. He continued developing innovative nanoparticle drug delivery solutions during pharmacy school and graduate school. This has launched him to his current position as the Applied Drug Delivery Fellows at Catalent Pharma Solutions as part of the Rutgers Pharmaceutical Industry Fellowship Program.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register